NEOTOPE BIOSCIENCES LTD has a total of 59 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROTHENA BIOSCIENCES LTD, VANCOUVER BIOTECH LTD and FACET BIOTECH CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | United States | 7 | |
#3 | China | 6 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Hong Kong | 4 | |
#7 | Republic of Korea | 4 | |
#8 | Taiwan | 3 | |
#9 | Chile | 2 | |
#10 | Singapore | 2 | |
#11 | South Africa | 2 | |
#12 | Argentina | 1 | |
#13 | Australia | 1 | |
#14 | Brazil | 1 | |
#15 | Colombia | 1 | |
#16 | Cuba | 1 | |
#17 | Israel | 1 | |
#18 | India | 1 | |
#19 | Peru | 1 | |
#20 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies | |
#6 | Unspecified technologies | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Nijjar Tarlochan S | 29 |
#2 | Saldanha Jose | 21 |
#3 | Barbour Robin | 18 |
#4 | Baker Jeanne | 10 |
#5 | Flanagan Kenneth | 10 |
#6 | Yednock Theodore A | 7 |
#7 | Schenk Dale B | 6 |
#8 | Liu Yue | 5 |
#9 | Basi Guriqbal S | 4 |
#10 | Jose Saldanha | 4 |
Publication | Filing date | Title |
---|---|---|
WO2015004632A1 | Antibodies that recognize iapp | |
WO2015004633A1 | Antibodies that recognize islet-amyloid polypeptide (iapp) | |
KR20150129736A | Tau immunotherapy | |
WO2014055967A2 | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition | |
TW201422639A | Anti-mcam antibodies and associated methods of use | |
CN104334184A | Humanized antibodies that recognize alpha-synuclein | |
EP2718327A1 | Mcam antagonists and methods of treatment | |
CA2832106A1 | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |